Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs386134256
rs386134256
MEN1
G 0.800 CausalMutation CLINVAR Clinical Features and Response to Treatment of Prolactinomas in Children and Adolescents: A Retrospective Single-Centre Analysis and Review of the Literature. 29455199

2018
dbSNP: rs386134256
rs386134256
MEN1
G 0.800 CausalMutation CLINVAR Is Routine Screening of Young Asymptomatic MEN1 Patients Necessary? 28321559

2017
dbSNP: rs386134256
rs386134256
MEN1
0.800 GeneticVariation UNIPROT Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. 27854360

2017
dbSNP: rs386134256
rs386134256
MEN1
G 0.800 CausalMutation CLINVAR Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1). 26224587

2016
dbSNP: rs386134256
rs386134256
MEN1
0.800 GeneticVariation UNIPROT A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. 25394175

2015
dbSNP: rs386134256
rs386134256
MEN1
0.800 GeneticVariation UNIPROT ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. 25356965

2015
dbSNP: rs386134256
rs386134256
MEN1
G 0.800 CausalMutation CLINVAR Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1. 25824098

2015
dbSNP: rs386134256
rs386134256
MEN1
G 0.800 CausalMutation CLINVAR Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours. 24443791

2014
dbSNP: rs386134256
rs386134256
MEN1
0.800 GeneticVariation UNIPROT ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. 23788249

2013
dbSNP: rs386134256
rs386134256
MEN1
0.800 GeneticVariation UNIPROT Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). 22723327

2012
dbSNP: rs386134256
rs386134256
MEN1
0.800 GeneticVariation UNIPROT American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. 20065170

2010
dbSNP: rs386134256
rs386134256
MEN1
G 0.800 CausalMutation CLINVAR Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value. 19350320

2009
dbSNP: rs386134256
rs386134256
MEN1
G 0.800 CausalMutation CLINVAR Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening. 17235589

2007
dbSNP: rs386134256
rs386134256
MEN1
G 0.800 CausalMutation CLINVAR Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1. 17853334

2007
dbSNP: rs386134256
rs386134256
MEN1
0.800 GeneticVariation UNIPROT Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. 15604628

2004
dbSNP: rs386134256
rs386134256
MEN1
0.800 GeneticVariation UNIPROT Guidelines for diagnosis and therapy of MEN type 1 and type 2. 11739416

2001
dbSNP: rs386134256
rs386134256
MEN1
G 0.800 CausalMutation CLINVAR Prospective controlled trial of a standardized meal stimulation test in the detection of pancreaticoduodenal endocrine tumours in patients with multiple endocrine neoplasia type 1. 11578300

2001
dbSNP: rs386134256
rs386134256
MEN1
G 0.800 CausalMutation CLINVAR MEN1 gene mutations in 12 MEN1 families and their associated tumors. 9820618

1998